000			01783 a2200505 4500
005			20250514221833.0
264		0	_c20050404
008			200504s 0 0 eng d
022			_a0002-9394
024	7		_a10.1016/j.ajo.2004.10.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aHolekamp, Nancy M
245	0	0	_aThe safety profile of long-term, high-dose intraocular corticosteroid delivery. _h[electronic resource]
260			_bAmerican journal of ophthalmology _cMar 2005
300			_a421-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdult
650	0	4	_aAngioid Streaks _xcomplications
650	0	4	_aCataract _xchemically induced
650	0	4	_aChoroid Diseases _xcomplications
650	0	4	_aChoroidal Neovascularization _xdrug therapy
650	0	4	_aDrug Delivery Systems
650	0	4	_aDrug Implants
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aFluocinolone Acetonide _xadministration & dosage
650	0	4	_aFollow-Up Studies
650	0	4	_aGlucocorticoids _xadministration & dosage
650	0	4	_aHistoplasmosis _xcomplications
650	0	4	_aHumans
650	0	4	_aIntraocular Pressure _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyopia, Degenerative _xcomplications
650	0	4	_aOcular Hypertension _xchemically induced
650	0	4	_aProspective Studies
650	0	4	_aRetinal Vein Occlusion _xchemically induced
650	0	4	_aSafety
650	0	4	_aTreatment Outcome
650	0	4	_aVisual Acuity
700	1		_aThomas, Matthew A
700	1		_aPearson, Andrew
773	0		_tAmerican journal of ophthalmology _gvol. 139 _gno. 3 _gp. 421-8
856	4	0	_uhttps://doi.org/10.1016/j.ajo.2004.10.005 _zAvailable from publisher's website
999			_c15439797 _d15439797